Treatment Modification Common With Second-Line Antidiabetic Meds
By Elana Gotkine HealthDay Reporter
THURSDAY, Dec. 14, 2023 -- Most patients with type 2 diabetes initiating antidiabetic medication (ADM) experience treatment modification within one year, according to a study published in the December issue of the American Journal of Managed Care.
David T. Liss, Ph.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues conducted a retrospective cohort study to describe changes in ADM use after initiation of noninsulin second-line therapy. Adults with type 2 diabetes who initiated one of five index ADM classes were analyzed; three treatment modification outcomes were assessed over 12-month follow-up.
The researchers found that 63.6 percent of the 82,624 included adults experienced any treatment modification. The most common modification was discontinuation (38.6 percent), especially among those prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs; 50.3 percent). Switching and intensification occurred in 5.2 and 19.8 percent of patients, respectively. In adjusted analyses, discontinuation risk was higher among patients prescribed dipeptidyl peptidase 4 inhibitors and GLP-1 RAs compared with those prescribed sulfonylureas (hazard ratios, 1.07 and 1.28, respectively). Higher risks of switching and lower risks of intensification were seen for all other index ADM classes compared with sulfonylureas. Higher risk of all modifications was seen in association with younger age group and female sex. Index prescription by an endocrinologist was associated with lower discontinuation risk and higher intensification risk compared with index prescription by a family medicine or internal medicine physician.
"Future research is needed to improve our understanding of barriers to ADM adherence among patients who discontinue second-line therapy," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Large Language Models May Aid Emergency Department Triage
TUESDAY, May 14, 2024 -- Large language models (LLMs) could enhance emergency department triage workflows, according to a study published online May 7 in JAMA Network...
Neighborhood Inequity Tied to More People Living With Vision Difficulty, Blindness
TUESDAY, May 14, 2024 -- Residential measures of inequity are associated with a greater number of individuals living with vision difficulty and blindness (VDB), according to a...
Elite Running Tied to Longer Life Expectancy
TUESDAY, May 14, 2024 -- Sub-four-minute mile runners have greater longevity than the general population, with results dating back as far as the 1950s, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.